LoRusso, Patricia M.
Gounder, Mrinal
Jalal, Shadia I.
André, Valérie
Kambhampati, Siva Rama Prasad
Loizos, Nick
Hall, Jennifer
Holzer, Timothy R.
Nasir, Aejaz
Cosaert, Jan
Kauh, John
Chiorean, E. Gabriela
Article History
Received: 8 September 2016
Accepted: 22 November 2016
First Online: 4 February 2017
Compliance with ethical standards
:
: P. M. LoRusso, M. Gounder, S. I. Jalal, and E. G. Chiorean disclosed no potential conflicts of interest. V. André, S. R. P. Kambhampati, N. Loizos, T. R. Holzer, A. Nasir, and J. Kauh are employees of Eli Lilly and Company. J. Cosaert and J. Hall were employed by Eli Lilly and Company during the conduct of the study but are now employed by Merck KGaA (Darmstadt, Germany) and Boehringer Ingelheim (Ridgefield, CT), respectively.
: This research was supported with funds from Eli Lilly and Company.
: This study was conducted in accordance with applicable laws and regulations, Good Clinical Practices, and the Declaration of Helsinki and with approval by the local Institutional Review Boards of participating institutions.
: Patients provided written informed consent before participating in the study.